In This Section

Sixth AACR-IASLC International Joint Conference: Lung Cancer Translational Science from the Bench to the Clinic


January 11-14, 2020
Marriott Marquis San Diego
San Diego, California


Conference Chairs

John V. Heymach, The University of Texas MD Anderson Cancer Center, Houston, Texas
Katerina A. Politi, Yale Cancer Center, New Haven, Connecticut


Conference Cochairs

Trever G. Bivona, University of California San Francisco, San Francisco, California
Christine M. Lovly, Vanderbilt University School of Medicine, Nashville, Tennessee

The American Association for Cancer Research (AACR) and the International Association for the Study of Lung Cancer (IASLC) are pleased to invite you to our sixth biennial international conference on lung cancer science. Established in 2010, this conference has historically joined a diverse group of attendees (physicians, patient advocates, and scientists in basic, translational, and clinical lung cancer research) and provided a venue to discuss recent advances and establish new collaborations. Sessions will range in topics spanning preneoplasia and early detection, immunotherapy, molecular targets, drug resistance, tumor progression, metastasis, and more. This conference is not only a dynamic collaboration of the AACR and the IASLC, two organizations committed to the study of cancer, but also a dynamic collaboration of the many individuals charged with the study and treatment of this disease.

This image has an empty alt attribute; its file name is AACRIASLClogos.png
This image has an empty alt attribute; its file name is IASLC-Logos-HZk-notag-2-004-002.png


Professional Educational Grants

AstraZeneca
Celgene
Novocure
Pfizer


Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available


#LUNG20